Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma

Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma

Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Asim Kichloo MD (Author), Michael S. Albosta MD (Author), Shane McMahon MD (Author), Kimberly Movsesian MD (Author), Farah Wani MD (Author), Shakeel M. Jamal MD (Author), Michael Aljadah MD (Author), Jagmeet Singh MD (Author)
Format: Book
Published: SAGE Publishing, 2020-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items